Background: The globular heads of the human C1q receptor (gC1qR) localize predominantly to the mitochondrial matrix. gC1qR mediates many biological responses, including growth perturbation, morphological abnormalities and the initiation of apoptosis. The purpose of this study was to investigate the relationship between mitochondrial dysfunction, p53 status and gC1qR expression and the regulation of apoptosis in human cervical squamous carcinoma cells (C33a and SiHa). Methods: Here, gC1qR expression was examined in human cervical tissues using real-time PCR and Western blot analysis. Apoptotic death of C33a and SiHa cells was assessed by flow cytometric analysis that detected the subG1 population. Mitochondrial function was assessed via ROS generation, the content of cytosolic Ca 2+ , and the change in mitochondrial membrane potential (Δψm). The viability and migration of C33a and SiHa cells were detected via the water-soluble tetrazolium salt (WST-1) assay and the transwell assay, respectively.
Background
Cervical cancer is the most common malignant gynaecological disorder worldwide [1] . The lack of preventive strategies, early diagnostic methods, and effective therapies to treat recurrent cervical tumours creates a pressing need to understand its pathogenesis and to identify molecular markers and targets for diagnosis and therapy [2, 3] . However, this involves the expression of both proand anti-apoptotic proteins that remain largely unknown.
The receptor for the globular heads of C1q, gC1qR/ p33, is a ubiquitous and highly anionic cellular protein of 33 kDa that was initially identified and characterised as a receptor for the globular heads of C1q [4] . There is evidence that gC1qR mediates many biological responses, including inflammation, infection and immune regulation [5] . gC1qR-induced T-cell dysfunction involves the induction of suppressor of cytokine signaling (SOCS), a powerful inhibitor of cytokine signalling, which represents a novel mechanism of action [6] . Indeed, examples of such responses include growth perturbation, morphological abnormalities and initiation of apoptosis [7] . The present study assessed the effect of gC1qR on the apoptosis of cervical squamous carcinoma cells, and investigated the gC1qR-induced activation of the p53-dependent pathway.
Materials and methods

Reagents
The C33a and SiHa cervical squamous carcinoma cell lines were obtained from Boster Technology (Wuhan, HuBei, China). The human cervical epithelial cell line CRL2614 was purchased from American Type Culture Collection (ATCC). The phototope-HRP Western Blot Detection System was purchased from Cell Signaling Technology (Beverly, MA, USA). 2', 7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) was obtained from Molecular Probes. A Flow Cytometry Assay Kit was purchased from Invitrogen. Antibodies directed against gC1qR, p53 and actin were purchased from Santa Cruz (Santa Cruz, CA, USA) and Cell Signaling Technology. The plasmids pCB6+ p53 and pCB6+ p53 173 L encode wild-type (wt) and mutant p53 (mt), respectively, and were kindly supplied by Hangzhou Hibio Bio-tech Co., Ltd. The initial amino acid before mutation for pCB6 + p53 173 L were kqsqhmtev (164-172). p53 small interference RNA (siRNA) and negative siRNA (An unrelated gene siRNA as a negative control) were synthesized by Wuhan Genesil Biotechnology Co., Ltd (Wuhan, China). Cell culture supplies were purchased from Life Technologies (Gaithersburg, MD, USA).
Tissue procurement and preparation
Human cervical cancer tissues were collected from 30 patients who underwent radical hysterectomy due to cervical carcinoma at Nanjing Maternity and Child Health Care Hospital between October 2007 and January 2010. Tumour specimens were obtained immediately after surgery. Local ethical approval was obtained before beginning this study and, where appropriate, tissues were collected with informed consent. The tumours and surrounding non-neoplastic tissues were reviewed by a pathologist and histologically confirmed.
Cell culture and DNA transfection
Cells were cultured in Dulbecco's modified Eagle's medium/Ham's F-12 medium containing 10% foetal bovine serum and 5 μg/mL insulin in a 37°C incubator with 5% CO 2 . Complementary DNA (cDNA) encoding gC1qR was cloned in frame using the BamHI/EcoRI sites into the pcDNA 3.1 expression plasmid (Invitrogen, Carlsbad, CA). The resulting gC1qR vector was then transfected into C33a and SiHa cells. 24 h after plating, cells were serum-starved for a further 24 h to synchronize cultures into quiescence. Following serum starvation, cells were transfected using LipofectAMINE ™ reagent (Life Technologies, Inc.) according to the vendor's protocol. Briefly, 0.05-1.5 μg/ml of plasmid DNA and 12 μg/ml LipofectAMINE ™ were diluted in serum-free DMEM. After incubation for 30 min at 37°C, the DNA-liposome complexes were then added dropwise to each culture dish and incubated at 37°C, 5% CO 2 for 12 h. Following transfection, cells were maintained in culture in serumfree DMEM. Reporter gene levels were normalised to total protein, and all results represent the average of triplicate experiments.
Real-time quantitative polymerase chain reaction (Real-time PCR)
Total RNA was isolated from tissues by using Trizol reagent (Invitrogen) according to the manufacturer's instructions. The isolated RNA was then DNase-treated and reverse-transcribed according to the manufacturer's instructions. Real-time PCR was performed using ABI PRISM 7300 sequence detection system (Applied Biosystems) with the following thermal cycling conditions: 2 min at 50°C, 10 min at 95°C followed by a total of 40 cycles of 15 s at 95°C and 1 min at 60°C. All reactions were conducted in a 50 μL reaction volume in triplicate. β-actin was used as an internal control in all PCR experiments. Relative amounts of gC1qR mRNA were normalised to β-actin mRNA: 
Western blot analysis
After various treatments, cells were collected and placed in sample buffer, and then the cells were incubated in lysis buffer and protease inhibitor mixtures for 30 min on ice. The supernatants were collected by centrifugation at 13,000 × g at 4°C for 15 min. An equal amount of protein was separated by SDS-PAGE on a 10-15% polyacrylamide gel and then transferred onto a PVDF membrane. The transferred membranes were blocked for 1 h in 5% nonfat milk in PBST (PBS containing 0.05% Tween-20) and incubated with appropriate primary antibodies and horseradish peroxidase-conjugated secondary antibodies. The protein bands were visualised using the enhanced chemiluminescence (ECL) Western Detection System.
Assay of intracellular ROS in C33a and SiHa Cells
C33a and SiHa cells were incubated with H 2 DCFDA (10 μM) under various conditions for 10 min in the dark and lysed with RIPA buffer in ice-cold conditions [8] . ROS levels were detected by fluorescence microscopy at an excitation wavelength of 488 nm and emission at 530 nm. A spectrofluorometer with a slit width of 5 nm was used to quantify the fluorescence in the supernatant. The results are shown as an increase in fluorescence intensity with respect to the normoxic untreated control after subtracting basal fluorescence.
Measurement of intracellular Ca
Fluo-4 AM fluorescence was used to quantify the intracellular Ca 2+ levels. The cells were resuspended in 1 mL of PBS and incubated with 5 mL of Fluo-4 AM 1 mM for 1 h. The fluorescence intensity was detected by a Beckman Coulter Paradigm ™ Detection Platform at an excitation wavelength of 485 nm and an emission wavelength at 530 nm. Fluorometric measurements were performed in ten different sets and are expressed as the fold increase in fluorescence per microgram of protein compared with the control group.
Measurement of mitochondrial membrane potential (Δψm)
JC-1 (Molecular Probes, Eugene, OR, USA) is a cationic mitochondria-specific fluorescent dye that was used to detect the loss of mitochondrial membrane potential (Δψm) [9] . At an excitation wavelength of 485 nm and emission at 530 nm, the dye accumulates in mitochondria with increasing Δψm in monomeric conditions. Cells were washed with serum-free medium and incubated with 10 μM JC-1 at 37°C. Then, cells were resuspended with medium containing 10% serum and fluorescence measured at the two different wavelengths. The data are representative of ten individual experiments.
Cell viability assay
We measured cell proliferating activity with the watersoluble tetrazolium salt (WST-1) assay (Roche Diagnostics, Mannheim, Germany). The WST-1 assay is a colorimetric method in which the dye intensity is proportional to the number of viable cells. Cells were seeded into 96-well microtiter plates at a concentration of 5 × 10 3 cells/well. After a 12 h incubation, cells were treated with various conditions for 48 h. After incubation, the cells were washed with PBS and the cell proliferation reagent WST-1 was added, then samples were incubated for 4 h. Sample absorbance was analysed with a bichromatic ELISA reader at 450 nm. All experiments were performed in triplicate with different passages of the C33a and SiHa cells.
In vitro migration assay
Cell migration was measured using 24 mm diameter chambers with 8 μm pore filters (Transwell, 6-well cell culture). C33a and SiHa cells were collected and resuspended at 7.5 × 10 6 cells/mL in serum-free medium, and a 0.2 mL cell suspension was added to the upper chambers. Then, the treatment medium (0.5 mL) was added to the lower chambers. The chambers were incubated for 48 h at 37°C in a humidified atmosphere of 5% CO 2 / 95% air. Next, the filters were fixed in 95% ethanol and stained with H.E. The upper surfaces of the filters were scraped twice with cotton swabs to remove non-migrated cells. The experiments were repeated in triplicate with different passages of the C33a and SiHa cells, and the migrated cells were counted microscopically (400 ×) in five different fields per filter.
Detection of apoptotic cells
Annexin V-FITC and PI staining were utilised to detect apoptotic C33a and SiHa cells by flow cytometric analysis. Cells were washed and resuspended with binding buffer before being transferred to a 5 mL tube. The cells were incubated in the dark for 15 minutes after the addition of 5 μL Annexin V and 5 μL PI. Binding buffer was then added to each tube, and the samples were analysed by a Beckman Coulter Epics XL flow cytometer.
Statistical analysis
Most results are presented as the mean ± standard deviation (SD). Differences between various data sets were tested for significance using a Student's t-test, and a p-value of less than 0.05 was considered significant (***p < 0.001; **p < 0.01; *p < 0.05;
Results
The expression of gC1qR in human cervical tissues
In order to investigate the levels of gC1qR gene and protein expression in human cervical squamous cell carcinomas, 30 cases of human cervical squamous cell carcinomas and surrounding non-neoplastic tissues were analysed by real-time quantitative polymerase chain reaction (real-time PCR) and Western blot ( Figure 1 ). The results showed that the mRNA expression and protein levels of gC1qR were significantly decreased in human cervical squamous cell carcinoma tissues (T) compared with the surrounding non-neoplastic tissues (N). This finding suggested that gC1qR might play a negative role in the survival of human cervical squamous cell carcinoma.
Comparison of gC1qR expression in human cervical squamous carcinoma cells and human cervical epithelial cells
Next, we determined the gC1qR expression levels in two cervical squamous carcinoma cell lines, C33a and SiHa, and a human cervical epithelial cell line, CRL2614 ( Figure 2 ). Real-time PCR and Western blot results showed that the level of gC1qR expression in C33a and SiHa cells was lower than that in CRL2614 cells. Thus, the C33a and SiHa cells were the primary focus of subsequent experiments.
Functional analysis of the effects of gC1qR treatment on cervical squamous carcinoma cell lines
To explore the function of gC1qR, it was overexpressed in C33a and SiHa cells. Both the mRNA and protein expression of gC1qR were detected in C33a and SiHa cells Figure 1 The levels of gC1qR in cervical tissues. Relative gC1qR gene and protein levels are shown for human cervical squamous cell carcinoma tissues (T) and surrounding non-neoplastic tissues (N). A: The mRNA levels of gC1qR were analysed by real-time PCR. **p < 0.01, significantly different when compared with surrounding nonneoplastic tissues (n = 30). B: The levels of gC1qR protein were measured by Western blot analysis. The graph shows the relative gC1qR protein levels, which were quantified and normalised to β-actin. Values are represented as the means ± SD. The gC1qR gene levels were low in human cervical squamous cell carcinoma tissues. **p < 0.01, significantly different when compared with surrounding non-neoplastic tissues (n = 30). transfected with either gC1qR vector or empty vector ( Figure 3A ), the levels of gC1qR were significantly increased after transfection with the gC1qR vector. Using these transfectants, we explored the biological effects of gC1qR overexpression on C33a and SiHa cells. Mitochondrial function was assessed via ROS levels, cytosolic Ca 2+ levels, and the change in Δψm. After transfection with the gC1qR vector or empty vector for 0, 24, 36, 48, 60, 72, and 84 h, ROS generation was determined by H 2 DCFDA fluorescence. ROS levels in the gC1qR vector group increased in a time-dependent manner, and maximum levels of ROS were detected 72 h after the transfection (Figure 3B-a) . As shown Figure 3B -b, cytosolic Ca 2+ was elevated 84 h after transfection. At this time, the [Ca 2+ ]i concentration of the gC1qR vector group was 3.68-fold that of the empty vector group. The elevation of cytosolic Ca 2+ also occurred in a time-dependent manner. Changes in the relative Δψm values in gC1qR-overexpressing C33a and SiHa cells were also explored over time. We used the JC-1 dye to monitor Δψm, which is determined by the 590 nm: 527 nm emission ratio. The value of Δψm in the gC1qR vector treatment group was approximately 73% less than that of the empty vector group at 84 h. Thus, the Δψm in cervical squamous carcinoma cells overexpressing gC1qR was decreased ( Figure 3B-c) .
To investigate the effect of gC1qR on human cervical squamous carcinoma cell viability, migration and apoptosis, C33a and SiHa cells were transfected with the gC1qR vector or empty vector. Cell viability was determined by a WST-1 assay. As shown in Figure 3C -a, overexpression of gC1qR decreased cell viability as compared with the empty vector group at 48 h and 72 h. Moreover, the viability of cells in the empty vector group did not change from 0 h to 72 h. The number of migrated cells was greatly decreased in cells overexpressing gC1qR compared with those transfected with the empty vector. The amount of migrated cells in the empty vector group did not change from 0 to 72 h ( Figure 3C-b) . In addition, to extend our work, the amount of apoptotic death of C33a and SiHa cells was assessed. A typical transfected human cervical squamous carcinoma cell that is undergoing apoptosis is indicated in Figure 3C -c and Additional file 1: Figure S1 . The results showed that overexpression of gC1qR increased the number of cervical squamous carcinoma cells in the subG1 region at 72 h. In contrast, the number of subG1 cells in the empty vector-transfected cells showed no change over time.
Overexpression of gC1qR in human cervical squamous carcinoma cells resulted in the production of p53, as shown in Figure 3D , Additional file 2: Figure S2 and Additional file 3: Figure S3 . We measured the levels of p53 after transfection with the gC1qR vector or empty vector for 0 h, 24 h, 48 h, and 72 h. These data found that p53 was notably increased in cervical squamous carcinoma cells transfected with gC1qR vector in a time-dependent manner. In contrast, no change in p53 expression was found in cells treated with the empty vector.
gC1qR affects mitochondrial function in C33a and SiHa cells via a p53-dependent pathway Cervical squamous carcinoma cells were transiently transfected with gC1qR vector or empty vector. At 72 h post-transfection, cells were transfected with 100 ng of empty pCB6 vector, which encodes p53 negative (-), 100 ng of pCB+ p53, which encodes wild-type p53 (wt), or 100 ng of pCB6+ p53 173 L, which encodes mutant p53 (mt). Co-expression of wild-type p53 and gC1qR increased the levels of gC1qR-induced ROS production by almost 21.9% at 72 h compared with the empty pCB6 vector + gC1qR vector group. In contrast, co-expression of the trans-dominant negative p53 173 L mutant and gC1qR decreased the level of gC1qR-induced ROS generation by almost 62.2% compared with the empty pCB6 vector + gC1qR vector group. Co-expression of wildtype p53 and empty vector increased ROS production compared with the empty pCB6 vector + empty vector group. The ROS production in the mutant p53 and empty vector group was no change compared with the empty pCB6 vector + empty vector group (p > 0.05). Moreover, the ROS levels was notably increased in cells transfected with the wild-type p53 and gC1qR vector when compared with the wild-type p53 and empty vector group, however, the ROS generation had no apparently different between the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05) (Figure 4A-a) . As shown in Figure 4A- pCB6 vector + gC1qR vector group. Furthermore, there was an increase in Δψm in C33a and SiHa cells transfected with the mutant p53 and gC1qR vectors group. Co-expression of wild-type p53 and empty vector decreased the value of Δψm compared with the empty pCB6 vector + empty vector group. The value of Δψm in the mutant p53 and empty vector group was no change compared with the empty pCB6 vector + empty vector group. Moreover, the value of Δψm was notably decreased in cells transfected with the wild-type p53 and gC1qR vector when compared with the wild-type p53 and empty vector group, however, the relative Δψm values had no apparently different between the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05) (Figure 4A-c) .
To determine if accumulated gC1qR affects mitochondrial dysfunction in C33a and SiHa cells via a p53-dependent pathway, cervical squamous carcinoma cells were transiently transfected with gC1qR vector or empty vector. At 72 h post-transfection, cells were transfected with p53 siRNA or negative siRNA (An unrelated gene siRNA as a negative control). Co-expression of gC1qR vector + p53 siRNA decreased the levels of gC1qR-induced ROS production by almost 63.4% at 72 h compared with the gC1qR vector group. However, the ROS production in gC1qR vector + negative siRNA group was no change compared with the gC1qR vector group (p > 0.05), in addition, the ROS generation had no apparently different between the empty vector + p53 siRNA group, empty vector + negative siRNA group and the empty vector group (p > 0.05). In contrast, the ROS levels was notably increased in cells transfected with the gC1qR vector when compared with the empty vector group, however, the ROS production in gC1qR vector + p53 siRNA group was no change compared with the empty vector + p53 siRNA group (Figure 4B-a) . As shown in Figure 4B- ]i levels had no apparently different between the gC1qR vector + p53 siRNA group and the empty vector + p53 siRNA group. The value of Δψm was apparently increased in cells co-expressing gC1qR vector and p53 siRNA compared with the gC1qR vector group, but the value of Δψm in the gC1qR vector + negative siRNA group was no change compared with the gC1qR vector group. However, the relative Δψm values had no apparently different between the empty vector + p53 siRNA group, empty vector + negative siRNA group and empty vector group (p > 0.05). The value of Δψm was notably decreased in cells transfected with gC1qR vector when compared with the empty vector group. However, the value of Δψm in the gC1qR vector + p53 siRNA group was no change compared with the empty vector + p53 siRNA group (Figure 4B-c) .
gC1qR overexpression induced biological effects via a p53-dependent pathway in C33a and SiHa cells
To investigate the effect of p53 on viability, migration and apoptosis in gC1qR-overexpressing human cervical squamous carcinoma cells, C33a and SiHa cells were transfected with gC1qR vector or empty vector, at 72 h post-transfection, cells were transfected with 100 ng of empty pCB6 vector, which encodes p53 negative (-), 100 ng of pCB+ p53, which encodes wild-type p53 (wt), or 100 ng of pCB6+ p53 173 L, which encodes mutant p53 (mt). As shown in Figure 5A -a, co-expression of wild-type p53 and gC1qR decreased cell viability compared with transfection with the empty pCB6 vector + gC1qR vector group, the viability of cells in the mutant p53 and gC1qR vector group was increased compared with the empty pCB6 vector + gC1qR vector group. Coexpression of wild-type p53 and empty vector decreased the viability of cells compared with the empty pCB6 vector + empty vector group. The viability of cells in the mutant p53 and empty vector group was no change compared with the empty pCB6 vector + empty vector group. Moreover, cell viability was notably decreased in cells transfected with the wild-type p53 and gC1qR vector when compared with the wild-type p53 and empty vector group, in contrast, the viability of cells had no apparently different between the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05). The number of migrated cells was significantly lower in the cells transfected with wildtype p53 and gC1qR vectors compared with the empty pCB6 vector + gC1qR vector group (p < 0.01). The numbers of migrated cells were different between mutant p53 + gC1qR vector group and empty pCB6 vector + gC1qR vector group. Co-expression of wild-type p53 and empty vector decreased the number of migrated cells compared with the empty pCB6 vector + empty vector group. The number of migrated cells in the mutant p53 and empty vector group was different compared with the empty pCB6 vector + empty vector group. Moreover, migrated cells were notably decreased in cells transfected with the wild-type p53 and gC1qR vector when compared with the wild-type p53 and empty vector group, however, the number of migrated cells had no apparently different between the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05) (Figure 5A-b) . As shown in Figure 5A -c, expression of the wild-type p53 and gC1qR vector increased the apoptosis of C33a and SiHa cells. The apoptosis of cervical squamous carcinoma cells in the group treated with the mutant p53 + gC1qR vector was lower than that in the empty pCB6 vector + gC1qR vector group (p < 0.05). Co-expression of wild-type p53 and empty vector increased apoptosis cells compared with the empty pCB6 vector + empty vector group. Apoptosis cells in the mutant p53 and empty vector group was different compared with the empty pCB6 vector + empty vector group. Moreover, apoptosis cells were notably increased in cells transfected with the wild-type p53 and gC1qR vector when compared with the wild-type p53 and empty vector group, however, there was no different in cell apoptosis between the p53 173 L mutant + gC1qR vector group and the p53 173 L mutant + empty vector group (p > 0.05).
To explore if accumulated gC1qR affects viability, migration and apoptosis in C33a and SiHa cells via a p53-dependent pathway, human cervical squamous carcinoma cells were transfected with gC1qR vector or empty vector, at 72 h post-transfection, cells were transfected with p53 siRNA or negative siRNA. As shown in Figure 5B -a, coexpression of gC1qR vector and p53 siRNA increased cell viability compared with transfection with the gC1qR Figure 5 Viability, migration and apoptosis of C33a and SiHa cells. A, a: C33a and SiHa cell viability was detected via a WST-1 assay. Sample absorbance was analysed using a bichromatic ELISA reader at 450 nm; b: The migration of cells was measured by Transwell assay. The migrated cells were counted microscopically (400 X) in five different fields per filter; c: Numbers of apoptotic cells were measured by flow cytometric analysis. These results are shown as the means ± SD from 3 independent experiments. *p < 0.05, **p < 0.01 versus p53 (-), gC1qR vector (+) and empty vector (-) group; Δ p < 0.05, vector group, the viability of cells had no apparently different between the gC1qR vector group and the gC1qR vector + negative siRNA group (p > 0.05). Moreover, the viability of cells in the empty vector + p53 siRNA group, empty vector + negative siRNA group was no change compared with the empty vector group. The viability of cells in the gC1qR vector group was decreased compared with the empty vector group. However, there was no difference between the gC1qR vector + p53 siRNA group and the empty vector + p53 siRNA group. The number of migrated cells was significantly increased in the cells transfected with gC1qR vectors and p53 siRNA compared with the gC1qR vector group (p < 0.01). The numbers of migrated cells were no difference between the gC1qR vector + negative siRNA group and the gC1qR vector group. Moreover, the number of migrated cells had no apparently different between the empty vector + p53 siRNA group, the empty vector + negative siRNA group and the empty vector group (p > 0.05). Migrated cells were notably decreased in cells transfected with the gC1qR vector when compared with the empty vector group. However, the number of migrated cells in the gC1qR vector and p53 siRNA group had no change compared with the empty vector + p53 siRNA group (Figure 5B-b) . As shown in Figure 5B -c, expression of the gC1qR vector and p53 siRNA decreased the apoptosis of C33a and SiHa cells. The apoptosis of cervical squamous carcinoma cells in the group treated with the gC1qR vector + negative siRNA had no difference compared with the gC1qR vector group (p > 0.05). Moreover, apoptosis cells in the empty vector + p53 siRNA group, empty vector + negative siRNA group were no different compared with the empty vector group. Apoptosis cells were notably increased in cells transfected with the gC1qR vector when compared with the empty vector group, however, there was no different in cell apoptosis between the gC1qR vector + p53 siRNA group and the empty vector + p53 siRNA group (p > 0.05). Taken together, these results strongly suggest that p53 activity is required for gC1qR-induced apoptotic cervical cancer cell death.
Discussion
Apoptosis is a programmed cell death process, which is a critical protective mechanism against carcinogenesis [10] . Therefore, induction of apoptotic cell death is a promising strategy for the prevention of cancer. Our goals in these experiments were to demonstrate that gC1qR strongly induced ROS production in mitochondria, and that this oxidative stress induced apoptosis through a p53-dependent pathway in cervical squamous carcinoma cells. The relationship between mitochondrial dysfunction, p53 status and gC1qR expression in the regulation of apoptosis has not been examined. We have shown previously that gC1qR is capable of inducing apoptosis in human cervical squamous carcinoma cells [11] . These findings constitute the first evidence for the mitochondria as a target of gC1qR-induced apoptosis in a p53-dependent fashion.
gC1qR is a multi-compartmental and multibinding, and thus multifunctional, cellular protein that is expressed in a wide range of tissues and cell types [12] . In the present study, our data demonstrated that gC1qR had low expression in human cervical squamous carcinoma tissues. The list of biologic responses mediated by gC1qR is extensive, including roles in inflammation, infection and immune regulation [13, 14] . When constitutively expressed in a normal murine fibroblast cell line, gC1qR induces growth perturbation, morphological abnormalities and apoptosis [15] . gC1qR has been extensively studied in a previous study, primarily as an inducer of apoptosis [16] . In the present study, we found that overexpression of gC1qR in cervical squamous carcinoma cells results in increased rates of apoptosis.
Recent cohort studies have shown that gC1qR is a conserved eukaryotic multifunctional protein that primarily localised in the mitochondrial matrix and on the cell surface [17] . Human gC1qR is expressed as a proprotein of 282 amino acids (aa) whose first 73 amino acids, containing a mitochondrial localization signal, are required for localizing the protein to the mitochondria and are subsequently cleaved to generate mature gC1qR. The mature form of gC1qR has been tied to apoptosis and autophagy via inducing mitochondrial dysfunction [18] . Increasing evidence suggests that mitochondrial dysfunction is linked to apoptosis initiated by cytotoxic factors such as ROS, which are generated in excess in defective mitochondria. These findings have focused attention on the role of the mitochondria in apoptosis. While it is not yet clear how mitochondria regulate apoptosis, it has been suggested that a megachannel of high conductance results in the loss of mitochondrial membrane potential and mitochondrial function [19, 20] . Our study demonstrated that gC1qR-treated C33a and SiHa cells overexpressing gC1qR resulted in the generation of ROS, which correlated with intracellular Ca 2+ accumulation. Thus, the continuation of ROS generation in gC1qR-overexpressing cells was associated with intracellular Ca 2+ accumulation, which may lead to mitochondrial dysfunction. It was expected that interference with electron transport by ROS and increased intracellular Ca 2+ would influence mitochondrial membrane potential. Indeed, loss in Δψm occurred in C33a and SiHa cells overexpressing gC1qR. These data support our theory that mitochondrial Ca 2+ overload occurs in gC1qR-overexpressing cells, followed by apoptosis due to Ca 2+ accumulation in the mitochondria, which suggests a role for gC1qR in mitochondrialdependent apoptosis.
In this report, we also demonstrated that p53 activity is required downstream of gC1qR in this apoptotic pathway. These findings suggest that the association between these two proteins might have an important role and opens a new field of investigation into the function of p53 in the biology of gC1qR-induced apoptosis of human cervical squamous carcinoma cells. There is evidence to suggest that gC1qR-induced apoptosis occurs via both a p53-dependent and a p53-independent pathway [16] . We showed that in C33a and SiHa cells, overexpression of gC1qR induces apoptosis; moreover, co-expression of wild-type p53 and gC1qR resulted in decreased viability and less gC1qR-induced migration. However, gC1qR inhibition of viability and migration can be abrogated by co-expression of a transdominant negative mutant of p53 or silence the gene of p53. The ratio of the pro-apoptotic Bax and the anti-apoptotic Bcl-2 ultimately determines whether a cell survives or dies through the mitochondrial death pathway [21] . Our data suggest that gC1qR-induced apoptosis is regulated principally by p53, and, accordingly, the ratio of Bax/Bcl-2 was decreased when cells were transfected with gC1qR and mutant p53 (data not shown). These findings strongly suggest that gC1qR induces apoptosis through a p53-dependent pathway in cervical squamous carcinoma cells.
Conclusion
We demonstrate that gC1qR plays an important role in cervical cancer cell apoptosis, that increased levels of gC1qR are important in this apoptosis and that gC1qR induces apoptosis through the mitochondrial pathway and p53-dependent pathway in human cervical squamous carcinoma cells.
Additional files
Additional file 1: Figure S1 . gC1qR induced cell apoptosis. Cervical squamous carcinoma cell line, C33a, SiHa and human cervical epithelial cell line, CRL2614 were treated with gC1qR vector or empty vector, respectively. At 48 h post-transfection, cells were subjected to flow cytometric analysis to detect apoptotic death. Apoptotic cells were quantitated by the percentage of cells with subG1 DNA content. **p < 0.01, # p > 0.05 versus the corresponding empty vector.
Additional file 2: Figure S2 . gC1qR induced the expression of p53. C33a and SiHa cells were transfected with the empty vector or gC1qR vector. At 0 h, 24 h, 48 h, and 72 h post-transfection, the mRNA levels of p53 were analysed by real-time PCR. The results are expressed as the means ± SD of three separate experiments. *p < 0.05, **p < 0.01, ***p < 0.001 significantly different when compared with empty vector group.
Additional file 3: Figure S3 . The levels of p53 expression. A: Relative p53 gene expression levels are shown in cervical squamous carcinoma cell line, C33a, SiHa and human cervical epithelial cell line, CRL2614. The different expression level of p53 were analysed by real-time PCR as described. ** p < 0.01 versus CRL2614 cells; B: The expression of the p53 protein was measured by Western blot analysis. The graph depicts the relative p53 protein levels normalised to actin. The results are expressed as the mean ± SD of three separate experiments. ** p < 0.01 versus CRL2614 cells.
